Filing Details
- Accession Number:
- 0001144204-18-050779
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-25 19:02:44
- Reporting Period:
- 2018-09-21
- Accepted Time:
- 2018-09-25 19:02:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 910267 | Titan Pharmaceuticals Inc | TTNP | Biological Products, (No Disgnostic Substances) (2836) | 943171940 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1412377 | Marc Rubin | 400 Oyster Point Blvd., Suite 505 So. San Francisco CA 94080 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-21 | 400,000 | $0.25 | 556,317 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Acquisiton | 2018-09-21 | 400,000 | $0.00 | 400,000 | $0.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 400,000 | 2018-09-25 | 2023-09-25 | No | 4 | A | Direct |
Billionaire Hedge Funds
